Code | 9680B | ||||||||||
MA number | 21/0727/11-S | ||||||||||
Product Form: | tbl flm 50x500 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 25.11.2011 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: | PIL_Levetiracetam 500 mg_05.2024.pdf |
SPC: | SPC_Levetiracetam 500 mg_05.2024.pdf |
Safety feature | Yes |
Data update: | 09.05.2024 |